CW

Charles Winter

Chief Technical Officer at Janux Therapeutics

Janux Therapeutics

California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Janux Therapeutics
Industry
research
Employees
100.0
Seniority
C suite
Annual Revenue
10588000.0

Technologies

Outlook WP Engine WordPress.org Mobile Friendly reCAPTCHA Google Font API Google Tag Manager Google Analytics Lever Gravity Forms Typekit Micro Remote AI

Keywords

biotechnology biotechnology: pharmaceutical preparations health care biotechnology research tumor-activated t cell immunotherapy tractr egfr-tractr psma-tractr immuno-oncology cancer treatment clinical trials antigen-targeting bispecific molecules precision oncology t cell engager immunomodulators tumor microenvironment drug candidates selective modulation immune response metastatic castration-resistant prostate cancer mcrpc drug development therapeutic index safety profile efficacy studies protein engineering cytokine release syndrome crs monoclonal antibodies cancer immunotherapy safety concerns drug targeting pharmacokinetics dose escalation biologics development tumor antigens antibody-linked drugs immune system stimulation tumor-specific activation protease-cleavable linkers pharmaceutical collaborations partnering opportunities fda approval advanced therapies research collaboration prostate cancer investor relations scientific publications clinical pipelines novel therapeutics immune checkpoint blockade health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans